How useful is the smartwatch ECG?
How useful is the smartwatch ECG?
复制标题
DOI：
10.1016/j.tcm.2019.10.010
复制
发表时间：
2020-10-01
影响因子：
9.3
通讯作者：
Martin, Seth S.
中科院分区：
文献类型：
--
作者：
Isakadze, Nino;Martin, Seth S.
苹果推出了一款新颖功能的Apple Watch（苹果公司）系列4，使消费者能够记录心律条并协助自我诊断房颤（AF）。该手表与一个应用程序配对，提供节奏的自动分类。该算法识别AF的能力已获得食品和药物管理局的批准。鉴于越来越多地使用直接面向消费者的设备，出现了关于在临床实践中使用此类设备及其特征的重要问题。目前尚不清楚如何将从这些设备中获得的数据最佳地纳入患者护理中，以及这对患者意味着什么。使用可穿戴设备的安全性也令人担忧。此外，心电图（ECG）功能生成的数据是否有益于公共健康还有待确定。我们讨论了苹果（Apple Inc.）新推出的心电图功能，并审查即将进行的试验，研究使用该技术的临床应用和结果。我们还回顾了关于卡尔迪亚（AliveCor Inc.）移动的和智能手表ECG技术，并简要讨论Apple Watch不规则心跳通知沿着Apple心脏研究。(C)2019作者（S）爱思唯尔公司出版
Apple launched a novel feature of the Apple Watch (Apple Inc.) series 4 that enables consumers to record a rhythm strip and assist with self-diagnosis of atrial fibrillation (AF). The watch is paired with an app that provides automatic classification of the rhythm. Ability of the algorithm to identify AF has received Food and Drug Administration clearance. Given increasing use of direct-to-consumer devices, important questions regarding the utilization of such devices and their features in clinical practice arise. It is unclear how the data obtained from these devices can be optimally incorporated in patient care and what it means for patients. Safety and security of using wearables are also of concern. Furthermore, whether data generated from the Electrocardiogram (ECG) feature will be beneficial to public health is to be determined. We discuss possible uses and challenges of Apple's (Apple Inc.) newly launched ECG feature and review an upcoming trial looking at clinical applications and outcomes using this technology. We also review the literature on the Kardia (AliveCor Inc.) mobile and smartwatch ECG technology and briefly discuss Apple Watch irregular heartbeat notifications along with the Apple Heart Study. (C) 2019 The Author(s). Published by Elsevier Inc.